Overview A Study to Evaluate the Safety, Tolerability, and PK in Healthy Volunteers and HCV Genotype 1 Infected Patients Status: Completed Trial end date: 2013-07-01 Target enrollment: Participant gender: Summary A Safety Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in HCV Genotype 1 Infected Patients Phase: Phase 1 Details Lead Sponsor: TaiGen Biotechnology Co., Ltd.